Clinical Trials Directory

Trials / Completed

CompletedNCT06785714

Colorectal Cancer Screening in Xinxiang City

Status
Completed
Phase
Study type
Observational
Enrollment
25,000 (actual)
Sponsor
The First Affiliated Hospital of Xinxiang Medical College · Academic / Other
Sex
All
Age
45 Years – 74 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to evaluate the sensitivity of the fecal protein dual-index test reagent for the detection of colorectal cancer (CRC).

Detailed description

The project uses fecal hemoglobin and transferrin dual-index combined with reagents that can be self-tested at home (referred to as fecal protein dual-index detection reagents), combined with colorectal cancer risk factor questionnaires, to carry out colorectal cancer screening in people of specific ages in the city, aiming to achieve early screening, early diagnosis and early treatment, and evaluate the effect of fecal protein dual-index detection reagents in early screening of colorectal cancer, so as to provide a scientific basis for optimizing the national screening program.

Conditions

Timeline

Start date
2024-09-01
Primary completion
2025-01-15
Completion
2025-01-15
First posted
2025-01-21
Last updated
2025-01-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06785714. Inclusion in this directory is not an endorsement.

Colorectal Cancer Screening in Xinxiang City (NCT06785714) · Clinical Trials Directory